Geron | GERN - Operating Expenses


Geron reported $61.11M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Amgen USD 5.13B 1.39B Sep/2025
Bio Techne USD 238.9M 101.93M Sep/2025
Cassava Sciences USD 11.86M 2.23M Sep/2025
Cytokinetics USD 168.69M 9.58M Sep/2025
Exelixis USD 341.4M 13.29M Sep/2025
Genmab DKK 565M 38M Jun/2025
Geron USD 61.11M 376K Sep/2025
Gilead Sciences USD 4.26B 95M Sep/2025
Incyte USD 4.65B 3.75B Sep/2025
MacroGenics USD 67M 8M Sep/2025
Novartis USD 9.86B 115M Sep/2025